On this page
SMAD3
SMAD family member 3
The SMAD3 gene provides instructions for a protein that plays a central role in the transforming growth factor-beta (TGF-β) signalling pathway, influencing cell growth, division, and movement. SMAD3 is a key gene involved in transmitting signals from outside the cell to the nucleus, helping to regulate various cellular processes.
SMAD3 is located on the long (q) arm of chromosome 15, at band 15q22.33. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 15 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The SMAD3 gene, also known as SMAD family member 3, encodes a protein essential for intracellular signal transduction within the transforming growth factor-beta (TGF-β) pathway. This pathway is fundamental for regulating a wide array of cellular functions, including cell proliferation, differentiation, and programmed cell death. Acting as a signal transducer, the SMAD3 protein conveys messages from cell surface receptors into the nucleus, where it influences which genes are activated or suppressed, thereby impacting processes like development and tissue repair.
When the normal function of the SMAD3 protein is disrupted, often due to genetic variants, various health conditions can arise. These conditions frequently involve connective tissue, which provides structural support throughout the body. Understanding the role of SMAD3 is therefore important for comprehending the mechanisms behind these disorders and for developing potential therapeutic strategies.
What the gene does
The SMAD3 gene is responsible for producing the SMAD3 protein, a pivotal component of the transforming growth factor-beta (TGF-β) signalling pathway. Signal transmission begins when a TGF-β ligand attaches to its corresponding receptor at the cell membrane. This attachment activates a collection of related SMAD proteins, with SMAD3 among them.
Once activated, SMAD3 assembles with other SMAD proteins into a functional protein complex. This newly formed complex travels into the cell nucleus. Within the nucleus, the SMAD assembly attaches to particular DNA sequences, controlling the transcription of specific genes. This transcriptional control is crucial for managing numerous cellular processes.
The SMAD3 protein significantly influences several aspects of cellular behaviour beyond gene regulation. It contributes to cell growth and division, cell movement, and controlled cell death. Through its coordinated action within the TGF-β pathway, SMAD3 ensures that extracellular signals are accurately converted into appropriate cellular responses, maintaining overall cellular function and tissue integrity.
Video: Genetics 101
Chromosome location
The SMAD3 gene is located on chromosome 15, specifically at position 15q22.33. This chromosomal address indicates its precise place within the long arm (q) of chromosome 15, within band 22, sub-band 33. The human genome contains approximately 20,000-25,000 protein-coding genes, each situated at a distinct locus on one of the 23 pairs of chromosomes. The location of SMAD3 contributes to its genetic neighbourhood and potential interactions with other genes in this region.
Protein structure
The SMAD3 protein consists of 425 amino acids and possesses a distinct domain architecture crucial for its function within the TGF-β signalling pathway. Two primary functional domains characterise the protein: the MH1 (Mad Homology 1) domain, spanning amino acids 10-136, and the MH2 (Mad Homology 2) domain, located from amino acids 232-425. The MH1 domain typically facilitates DNA attachment, enabling the protein complex to control gene expression. Between these domains lies a Linker region, situated from amino acids 137 to 231. A Disordered region (from amino acids 165-208) exists within this Linker and may provide protein flexibility and facilitate interactions.
The MH2 domain serves a critical role in protein-protein interactions, such as assembling complexes with other SMAD proteins and engaging with receptor kinases. One particular segment within the MH2 domain, spanning amino acids 271-324, has been shown sufficient for engaging with XPO4, a protein involved in nuclear export. This interaction demonstrates the importance of the MH2 domain in the nucleocytoplasmic shuttling of SMAD3, which is essential for its role in signal transduction.
Key variants
Genetic variants in the SMAD3 gene can alter the function of the SMAD3 protein, potentially affecting the intricate TGF-β signalling pathway. These changes can range from single nucleotide polymorphisms to larger deletions or insertions within the gene sequence. Depending on their nature and location, variants may lead to a non-functional protein, a protein with altered activity, or even an absence of the protein entirely.
The clinical significance of SMAD3 variants can vary widely. Some variants may be benign, having no noticeable effect on health, while others are pathogenic, meaning they are disease-causing. The impact of a variant often depends on its effect on the critical MH1 and MH2 domains or the linker regions, which are essential for DNA binding, protein-protein interactions, and overall signal transduction. The interpretation of SMAD3 variants requires careful consideration of genetic, clinical, and functional data to determine their potential contribution to an individual's health.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1010-1G>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | not provided |
c.1086_1098dup | p.Thr367fs | Pathogenic/Likely pathogenic | ★★☆☆ | not provided |
c.1087_1090del | p.Val363fs | Pathogenic/Likely pathogenic | ★★☆☆ | Familial thoracic aortic aneurysm and aortic dissection |
c.1102C>T | p.Arg368Ter | Pathogenic | ★★☆☆ | not provided |
c.1139G>A | p.Trp380Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Familial thoracic aortic aneurysm and aortic dissection |
c.1141G>T | p.Gly381Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Familial thoracic aortic aneurysm and aortic dissection |
c.1166_1167del | p.Val389fs | Pathogenic/Likely pathogenic | ★★☆☆ | Familial thoracic aortic aneurysm and aortic dissection |
c.1179dup | p.Cys394fs | Pathogenic/Likely pathogenic | ★★☆☆ | Familial thoracic aortic aneurysm and aortic dissection |
c.154G>T | p.Glu52Ter | Pathogenic | ★★☆☆ | not provided |
c.1A>C | p.Met1Leu | Pathogenic/Likely pathogenic | ★★☆☆ | Familial thoracic aortic aneurysm and aortic dissection |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the SMAD3 gene are associated with inherited conditions primarily affecting connective tissue. One notable condition is Familial Thoracic Aortic Aneurysm and Dissection, an autosomal dominant disorder. This condition involves the abnormal widening (aneurysm) and tearing (dissection) of the aorta, the body's main artery, particularly in the chest region. These aortic issues can lead to serious cardiovascular complications and require careful medical management.
SMAD3 variants are also linked to Loeys-Dietz syndrome type III, a connective tissue disorder. Research indicates that at least 35 mutations in the SMAD3 gene have been identified as causing this condition. Loeys-Dietz syndrome type III typically presents with features affecting various body systems due to widespread connective tissue involvement, often including an increased risk of aortic aneurysms and dissections.
Inheritance pattern
Conditions caused by pathogenic SMAD3 variants typically follow autosomal dominant inheritance.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
UK clinical status
The SMAD3 gene is recognised within the UK's clinical genomics framework, featuring on several NHS Genomic Medicine Service (GMS) pathways through PanelApp. This inclusion signifies its clinical relevance for diagnostic testing in the UK. SMAD3 is green-rated on panels for Arthrogryposis, Clefting, DDG2P, Ehlers Danlos syndrome with a likely monogenic cause, Foetal anomalies, Skeletal dysplasia, and Thoracic aortic aneurysm or dissection (both general and GMS-specific panels). This widespread inclusion highlights the gene's importance across a spectrum of inherited conditions.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Diet & lifestyle considerations
Research suggests that certain lifestyle factors may influence cardiovascular health, which is particularly relevant for individuals with genetic predispositions to conditions like thoracic aortic aneurysm and dissection. Maintaining a healthy weight through a balanced diet and regular physical activity is generally recommended for overall cardiovascular well-being. A diet rich in fruits, vegetables, and whole grains, while being low in saturated fats, cholesterol, and sodium, can contribute to heart health. Regular, moderate-intensity exercise, as advised by a healthcare professional, can also be beneficial for maintaining blood pressure and arterial health.
Evidence indicates that avoiding smoking is associated with improved cardiovascular outcomes, as tobacco use is a significant risk factor for cardiovascular disease and can exacerbate aortic conditions. Similarly, some studies suggest that managing stress through techniques like mindfulness or meditation may contribute positively to overall health. It is essential for individuals with specific genetic predispositions to consult with their healthcare provider to develop a personalised lifestyle plan that considers their unique health profile and any associated risks.
Supplement considerations
There is currently no conclusive evidence to suggest that specific dietary supplements can prevent or treat conditions associated with SMAD3 gene variants, such as Familial Thoracic Aortic Aneurysm and Dissection. While some supplements are marketed for cardiovascular health, their efficacy and safety, particularly in genetically predisposed individuals, are not well established. For example, some studies indicate that certain vitamins and minerals, such as Vitamin D or magnesium, might play a role in general cardiovascular function, but these are population-level observations and not specific to SMAD3-related conditions. Individuals should exercise caution and critically evaluate claims made about supplements.
Healthcare providers typically recommend discussing any intentions to take supplements with a doctor. A medical professional can offer guidance on whether a supplement is appropriate, considering individual health status, potential interactions with medications, and the lack of robust evidence for their benefit in specific genetic conditions. Relying solely on supplements without appropriate medical care is not recommended.
Frequently asked questions
What is the primary function of the SMAD3 gene?
The SMAD3 gene provides instructions for making a protein that is crucial in the transforming growth factor-beta (TGF-β) signalling pathway, helping to transmit chemical signals from the cell surface to the nucleus to regulate cell functions like growth, division, and movement.
What conditions are associated with pathogenic SMAD3 variants?
Pathogenic variants in the SMAD3 gene are primarily associated with connective tissue disorders, most notably Familial Thoracic Aortic Aneurysm and Dissection, which affects the aorta. They can also cause Loeys-Dietz syndrome type III.
How is the SMAD3 gene inherited?
Variants in the SMAD3 gene are typically inherited in an autosomal dominant pattern. This means that only one copy of the altered gene in each cell is sufficient to cause the condition.
Where is the SMAD3 gene located in the human genome?
The SMAD3 gene is located on chromosome 15, specifically at position 15q22.33, which is on the long arm of chromosome 15.
Are there specific lifestyle recommendations for individuals with SMAD3 variants?
General cardiovascular health recommendations, such as maintaining a healthy weight, regular exercise, a balanced diet, and avoiding smoking, are generally beneficial. Any specific lifestyle changes should be discussed with a healthcare provider.
What is the role of the TGF-β pathway in which SMAD3 operates?
The TGF-β pathway is a crucial signalling system that allows the environment outside the cell to influence internal cellular functions. When activated, this pathway regulates the production of proteins and controls cellular processes including growth, division, movement, and programmed cell death. SMAD3 acts as a key messenger within this pathway, transmitting signals from the cell surface to the nucleus.
References
- Liu L, Liu X, Ren X. Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification. Scientific reports. 2016. PMID: 26905010
- Wischmeijer A, Van Laer L, Tortora G. Thoracic aortic aneurysm in infancy in aneurysms-osteoarthritis syndrome due to a novel SMAD3 mutation: further delineation of the phenotype. American journal of medical genetics. Part A. 2013. PMID: 23554019
- van de Laar IM, van der Linde D, Oei EH. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. Journal of medical genetics. 2012. PMID: 22167769
- van de Laar IM, Oldenburg RA, Pals G. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nature genetics. 2011. PMID: 21217753
- Regalado ES, Guo DC, Villamizar C. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circulation research. 2011. PMID: 21778426